Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 832916, 8 pages
http://dx.doi.org/10.1155/2015/832916
Research Article

Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus

1Department of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
2Department of Rheumatology and Immunology, Pingxiang People’s Hospital, Pingxiang, Jiangxi 337055, China

Received 19 September 2014; Revised 12 December 2014; Accepted 15 December 2014

Academic Editor: Jianying Zhang

Copyright © 2015 Guang Fu Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Anolik, “B cell biology: implications for treatment of systemic lupus erythematosus,” Lupus, vol. 22, no. 4, pp. 342–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Gatto, M. Zen, A. Ghirardello et al., “Emerging and critical issues in the pathogenesis of lupus,” Autoimmunity Reviews, vol. 12, no. 4, pp. 523–536, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Paunovic, N. A. Carter, T. Thalhamer et al., “Immune complex-mediated co-ligation of the BCR with FcγRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosus,” Journal of Autoimmunity, vol. 39, no. 4, pp. 332–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. P. Kil, M. J. W. de Bruijn, M. van Nimwegen et al., “Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice,” Blood, vol. 119, no. 16, pp. 3744–3756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Jacob, S. Guo, A. Mathian et al., “B cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice,” Journal of Immunology, vol. 186, no. 8, pp. 4984–4993, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Simons and E. Ikonen, “Functional rafts in cell membranes,” Nature, vol. 387, no. 6633, pp. 569–572, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Gupta and A. L. DeFranco, “Lipid rafts and B cell signaling,” Seminars in Cell and Developmental Biology, vol. 18, no. 5, pp. 616–626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Freeman, V. Lei, M. Dang-Lawson, K. Mizuno, C. D. Roskelley, and M. R. Gold, “Cofilin-mediated F-actin severing is regulated by the Rap GTPase and controls the cytoskeletal dynamics that drive lymphocyte spreading and BCR microcluster formation,” The Journal of Immunology, vol. 187, no. 11, pp. 5887–5900, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Holowka, E. D. Sheets, and B. Baird, “Interactions between FcεRI and lipid raft components are regulated by the actin cytoskeleton,” Journal of Cell Science, vol. 113, no. 6, pp. 1009–1019, 2000. View at Google Scholar · View at Scopus
  10. S. Krishnan, M. P. Nambiar, V. G. Warke et al., “Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus,” The Journal of Immunology, vol. 172, no. 12, pp. 7821–7831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G.-M. Deng and G. C. Tsokos, “Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation,” The Journal of Immunology, vol. 181, no. 6, pp. 4019–4026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. C. Jury, P. S. Kabouridis, F. Flores-Borja, R. A. Mageed, and D. A. Isenberg, “Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus,” The Journal of Clinical Investigation, vol. 113, no. 8, pp. 1176–1187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. McDonald, S. Deepak, L. Miguel et al., “Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients,” Journal of Clinical Investigation, vol. 124, no. 2, pp. 712–724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Flores-Borja, P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed, “Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 56, no. 1, pp. 291–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G.-C. Wu, X.-D. Xu, Q. Huang, and H. Wu, “Leflunomide: friend or foe for systemic lupus erythematosus?” Rheumatology International, vol. 33, no. 2, pp. 273–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. C. Breedveld and J.-M. Dayer, “Leflunomide: mode of action in the treatment of rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 59, no. 11, pp. 841–849, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Bombardier, D. D. Gladman, M. B. Urowitz et al., “Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE,” Arthritis & Rheumatism, vol. 35, no. 6, pp. 630–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Blank, M. Schiller, S. Krienke, G. Wabnitz, A. D. Ho, and H.-M. Lorenz, “Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1,” Immunology and Cell Biology, vol. 85, no. 5, pp. 378–382, 2007. View at Publisher · View at Google Scholar
  21. P. W. Janes, S. C. Ley, and A. I. Magee, “Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor,” The Journal of Cell Biology, vol. 147, no. 2, pp. 447–461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Rosado, A. P. Diamanti, F. Capolunghi, and R. Carsetti, “B cell modulation strategies in autoimmunity: the SLE example,” Current Pharmaceutical Design, vol. 17, no. 29, pp. 3155–3165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Wei, J. Anolik, A. Cappione et al., “A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus,” The Journal of Immunology, vol. 178, no. 10, pp. 6624–6633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Peter, R. C. Budd, J. Desbarats et al., “The CD95 receptor: apoptosis revisited,” Cell, vol. 129, no. 3, pp. 447–450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Jenks and I. Sanz, “Altered B cell receptor signaling in human systemic lupus erythematosus,” Autoimmunity Reviews, vol. 8, no. 3, pp. 209–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Gupta and A. L. DeFranco, “Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation,” Molecular Biology of the Cell, vol. 14, no. 2, pp. 432–444, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Grahnert, C. Klein, E. Schilling, J. Wehrhahn, and S. Hauschildt, “NAD+: a modulator of immune functions,” Innate Immunity, vol. 17, no. 2, pp. 212–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hao and A. August, “Actin depolymerization transduces the strength of B-cell receptor stimulation,” Molecular Biology of the Cell, vol. 16, no. 5, pp. 2275–2284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Sweet, S. Mahdavian, A. Singh, P. Ghazvini, T. McKinnon, and D. Jones, “An update on the management of systemic lupus erythematosus,” Journal of Hematological Malignancies, vol. 3, no. 2, pp. 16–23, 2013. View at Publisher · View at Google Scholar
  30. S. Kalloo, N. Aggarwal, P. Mohan, and J. Radhakrishnan, “Lupus nephritis: treatment of resistant disease,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 1, pp. 154–161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. S. Zhang, Y. K. Nie, X. M. Jin, H. M. Yu, Y. N. Li, and Y. Sun, “The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy,” Rheumatology International, vol. 29, no. 11, pp. 1331–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus